CDEK by Data4ThePeople

Sign in Sign up

← All organizations

Adams Respiratory Therapeutics

For profitContributed to NME

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

Last known activity

Feb 1, 2007

Acquired by Reckitt Benckiser Pharmaceutical on Dec 10, 2007

Timeline

1990s

Jan 1, 1997
Adams Respiratory Therapeutics— Founded

2000s

Dec 10, 2007
Reckitt Benckiser Pharmaceutical— Acquired By

Drugs by trial phase (2 distinct, 2 trials)

Phase 4 (1 own, 0 via acquisition)

guaifenesin

Phase 2 (1 own, 0 via acquisition)

erdosteine

Indications

Approved for

Studied for

Marketed drugs (1)

guaifenesin

Recent trials (4)

NCT00441246Lead sponsorPhase 4Feb 1, 2007
NCT00441246Study chairPhase 4Feb 1, 2007
NCT00338507Study directorPhase 2Mar 1, 2006
NCT00338507Lead sponsorPhase 2Mar 1, 2006

Details

Founded: Chester, NJ, US Jan 1, 1997
Last known activity: Feb 1, 2007